On this #InternationalWomen’sDay, we honor the incredible women whose dedication, expertise, and leadership drive innovation at IGC Pharma and beyond. Your #contributions are shaping the future of #healthcare, and we are grateful for your talent and #passion every day. ? We are #proud to foster an environment where #women thrive, lead, and shape the projects that build our Company. Thank you for your work and your passion! ? #InternationalWomensDay #IWD2025 #WomenInScience #WomenInLeadership #IGCPharma
关于我们
IGC PHARMA is a Pharmaceutical company based in Maryland.
- 网站
-
https://igcpharma.com
IGC Pharma的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Potomac,MD
- 类型
- 上市公司
- 创立
- 2005
地点
IGC Pharma员工
-
Ram Mukunda
CEO - IGC Pharma, Inc.
-
Andrés Felipe Sánchez Díez, Ph.Dc Social Sciences.
M.B.A., Postgraduate Diploma in Senior Management, and another in Digital Business - Massachusetts Institute of Technology; a distinguished career as…
-
Julio César Sánchez Herrera
Media Content Creator
-
Juan Manuel Orjuela Rojas
Neuropsiquiatría | Neuromúsica
动态
-
Ascendiant Capital Markets, LLC?publishes an updated research #report with a #pricetarget of $4.25. Read more at: https://lnkd.in/eWdRTqRp
-
-
IGC Pharma Expands Holiby? with #Science-Backed Longevity Solutions? The global anti-aging #market is on a rapid trajectory, projected to surpass $182 billion by 2028. Consumers are prioritizing #cellularhealth, #cognitive support, and #sustained #energy, and IGC Pharma is meeting this demand with the expansion of Holiby?—introducing #Longevity and #Renew #Gummies. Backed by #science and formulated with NAD+ boosters, #adaptogens, and #functionalmushrooms, these new products support #healthy aging and #energy #metabolism—bridging the gap between #wellness and longevity research. Full info here: https://lnkd.in/evFkrF8G #igcpharma #functionalmushrooms #Longevity #Renew #WellnessInnovation #Holiby
-
-
IGC Pharma Expands into $75 Billion #Wellness #Market with the Launch of Holiby? ? IGC Pharma, Inc. is excited to introduce Holiby?, a wellness brand offering scientifically formulated products for immune defense and sustained #energy. This expansion into the thriving $75 billion wellness industry creates a new #revenue stream while IGC Pharma continues advancing its #pharmaceutical pipeline for #Alzheimer’s #disease and #metabolicdisorders. ? Holiby? products will be manufactured and distributed using IGC Pharma’s state-of-the-art facilities in Washington State, originally established for pharmaceutical production. This ensures high-quality formulations backed by #science and #innovation. ? Holiby? #Immunity #Gummies – With #Elderberry, #Echinacea, and #Reishi to support #immune #resilience. ? Holiby? #Energy Gummies – Featuring #Ashwagandha, #Ginseng, and #MacaRoot for stamina and #cognitive #performance. For more information and to explore our products, visit https://holiby.us/ #HolibyWellness #IGCPharma #Wellness #pharmaceutical #Alzheimer
-
-
#Proud moment for IGC Pharma! We are thrilled to share that we've been named one of the top 15 finalists in the #NIA's prestigious #PREPAREChallenge. This recognition highlights our groundbreaking work in leveraging #AI and multilingual models to detect #Alzheimer’s disease early ensuring accessibility and accuracy for #diversepopulations. ? Why does this matter? Over 7 million #Americans are living with #Alzheimer’s, and the need for #innovativesolutions has never been greater. By analyzing voice-based acoustic #biomarkers, our approach could transform #earlydiagnosis and improve outcomes globally. ? What’s next? In the upcoming stage, we’ll showcase how our AI technology detects cognitive changes across #demographicgroups while enhancing model interpretability. This is one step closer to redefining Alzheimer’s #care. ? Stay tuned for updates on how IGC Pharma is driving meaningful change in Alzheimer’s #diagnostics and #treatment. ? #Alzheimers #IGCPharma #EarlyDiagnosis #AIMedTech?#PREPAREChallenge?#GlobalHealth?#AI
-
-
Ever wondered how #medications “know” where to work in your body? From absorption to excretion, the journey of a drug is a fascinating interplay of #science and #biology. In this article, we dive into the world of #pharmacokinetics unpacking how drugs navigate through the body, cross barriers like the #blood-#brain barrier, and ensure #therapeutic effects while maintaining #safety. ? #Discover how advancements in pharmacokinetics shape the future of drug development and patient care by our Senior Medicinal Chemist, Dr. Diego Rodríguez-Soacha. ? ?? Read the full article here to explore the #science behind the #pills in your cabinet. https://lnkd.in/eTe5EUfB #alzheimersresearch #igcpharma #Pharmacokinetics #DrugDevelopment #HealthcareInnovation
-
-
We are excited to announce that former #Virginia Governor Terry McAuliffe has joined IGC Pharma as Strategic #Advisor! Governor McAuliffe brings a wealth of #leadership experience, including his efforts to strengthen the #biosciences industry and support transformative #healthcare initiatives. As a proven leader in both public and private sectors, he has consistently championed innovation and collaboration to tackle complex challenges. At IGC Pharma, we’re advancing #Alzheimer’s care with IGC-AD1, our investigational #therapy targeting #agitation in #dementia. With Governor McAuliffe’s guidance, we aim to further our research and development efforts, explore #therapies for #metabolicdisorders, and leverage #AI for enhanced drug discovery. Together, we’re addressing some of the most critical healthcare challenges of our time. Learn more about this exciting #partnership: https://lnkd.in/gJbnh_XB #leadership #HealthcareInnovation #alzheimerscare #AIinHealthcare #igcpharma
-
-
Join IGC Pharma at the Ascendiant Capital Markets, LLC Fireside Chat on January 23, 2025, for an exclusive look into our latest advancements in #biotechnology. ? In conversation with Edward Woo, CEO Ram Mukunda and CCO Claudia Grimaldi will discuss: ? How IGC-AD1’s dual mechanism of action is transforming #Alzheimer’s #treatment. ? How #AI is revolutionizing #drugdiscovery, from identifying molecules to optimizing #trial protocols. ? The market potential for disease-modifying #therapies compared to Alzheimer’s #agitation therapies. ? Discover how IGC is tackling #clinicaltrial challenges, such as recruitment barriers and diverse representation while expanding its presence in the rapidly growing disease-modifying therapy market. ? 2025 marks a transformative year for IGC—don’t miss this exclusive discussion! ? Learn more and register here: https://lnkd.in/e73UBc7K
-
-
Driving Innovation in #Alzheimer’s Care Our Phase 2 “CALMA” #clinicaltrial is tackling one of the most pressing challenges in Alzheimer’s care: #agitation. With an innovative geofencing recruitment strategy achieving a remarkable 200-300% enrollment increase at pilot sites and plans to scale across additional trial locations, we’re making significant strides toward improving the lives of #patients and #Caregivers. By combining advanced digital tools with compassionate care, CALMA is reshaping the future of Alzheimer’s #treatment. Learn more about how we’re advancing toward key #Milestones in Alzheimer’s care: https://lnkd.in/e7W37k5w #alzheimersresearch #igcpharma #InnovationInMedicine #clinicaltrials #caregiving #CALMAclinicaltrial
-
-
-
-
-
+1
-
-
Advancing #Hope in #Alzheimer’sCare At IGC Pharma, we’re driving #innovation with IGC-AD1, an investigational therapy tackling #cognitivedecline and disease markers like #amyloidplaques and #tautangles ? Interim?#Phase2 Highlights: #Improvedcognition and #reducedagitation. As we prepare for new trials in 2025, we’re excited to be moving closer to transforming Alzheimer’s care. ? Read the full article here: https://lnkd.in/ezgfXg3T ? #AlzheimersResearch #IGCPharma #CognitiveHealth #InnovationInMedicine